Dr. Shridharani Among First To Use Recently FDA Approved Injectable For Cellulite
Although QWO is officially FDA approved, it will not be ready commercially until 2021. Dr. Shridharani says this time allows for adequate training and education for physicians all over the country to begin using QWO. Dr. Shridharani has the unique opportunity to treat select patients with QWO before the full commercial launch in a host of various study-related activities. “We already have a waitlist of patients who want to be treated,” says Dr. Shridharani. “I’m not totally surprised considering how much cellulite bothers my patients, “ he adds.
